Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mark W. Dodson, Kelli Sumner, Jadyn Carlsen, Meghan M. Cirulis, Emily L. Wilson, Abhishek Gadre, Timothy M. Fernandes, Lynette M. Brown, D. Hunter Best, C. Gregory Elliott. The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension. Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020

Member's Comments

No comment yet.

Related content which might interest you: The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002 Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 736-741 Year: 2008 Type of anticoagulant therapy as a risk factor for the severity of chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Source: Eur Respir J 2003; 21: 25-30 Year: 2003 The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017 Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2011; 39: 125-132 Year: 2012